28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Related
Rehabilitation Facility Fired Employee Because of Her Need for Additional Leave to Recover From Cesa...
Read More >
At both the state and federal level, antitrust enforcement agencies continue to pursue successful ch...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
Previously we posted on our blog about a deadline looming in the distance for 403(b) plan sponsors t...
Read More >
Indemnification clauses appear in nearly every agreement, but they are often overlooked as mere boil...
Read More >
Chris Fairey, General Counsel for American Residential Services, one of the nation’s largest reside...
Read More >